C&G Editor in Chief, Erin Harris

31. Inside Cell & Gene Live "How To Reduce Batch-To-Batch Variation In Cell Therapy Manufacturing" 2/26/2024

    Here's a recap of our recent Cell & Gene Live, How to Reduce Batch-to-Batch Variation in Cell Therapy Manufacturing, featuring expert panelists, Omkar Kawalekar, Ph.D., Head of Manufacturing and Supply Chain at NextGen Therapies Consulting at Deloitte and Donna Rill, Chief Technology Officer at Triumvira Immunologics.

32. Mass General Cancer Center's Dr. Genevieve Boland on Amtagvi Approval 2/26/2024

    The FDA’s approval of Amtagvi addresses an unmet need in melanoma patient care. Here, Genevieve Boland, M.D., Ph.D., from Mass General Cancer Center shares her insight on the approval.

33. Inside Cell & Gene Live “2024 Regulatory Outlook With FDA's Dr. Peter Marks And Dr. Nicole Verdun” 1/30/2024

    In case you missed it, our recent Cell & Gene Live, 2024 Regulatory Outlook with FDA’s Dr. Peter Marks and Dr. Nicole Verdun, is available on demand. Here's a summary of the event.

34. Kriya Therapeutics' Announcements At JPM 1/22/2024

    I caught up with Kriya Therapeutics' Dr. Shankar Ramaswamy to discuss the company's announcements at JPM 2024.

35. ARM's State Of The Industry Briefing At JPM 2024 1/9/2024

    Here's a recap of ARM’s CEO Tim Hunt's 2024 State of the Industry Briefing presentation at JPM 2024.

36. Cell & Gene: The Podcast Episodes From ARM's 2023 MOTM 12/21/2023

    All three episodes of Cell & Gene: The Podcast recorded at ARM's 2023 Meeting on the Mesa have now aired. Here's a look at my guests and the important CGT topics we discussed.

37. iCell, Coeptis On FDA's Investigation Of CAR T Immunotherapies 12/18/2023

    Last month, the FDA stated it was investigating serious risks of T-cell malignancies in patients following treatment with a chimeric antigen receptor (CAR) T-cell therapies. I met up with Yupo Ma M.D., Ph.D. Chief Scientific Officer at iCell Gene Therapeutics, and Dave Mehalick, CEO and Colleen Delaney, M.D., Chief Scientific and Medical Officer at Coeptis Therapeutics to get their reaction to the FDA’s investigation.

38. Moving Beyond AAV: The Next Generation Of Vectors In CGT 12/11/2023

    We catch up with Dr. Konstantin Konstantinov, CTO at Ring Therapeutics, and Ryan Crisman, Ph.D., cofounder and CTO at Umoja Biopharma, to get their thoughts on the future of new anellovirus vectors and existing lentiviral vector technology for in vivo gene delivery respectively.

39. Video Clips From Cell & Gene Live: Optimizing Your Cold Chain For Cell Therapies 11/30/2023

    For your convenience, we’ve broken down our Cell & Gene Live, Optimizing Your Cold Chain for Cell Therapies, into bite-size video clips by topic.

40. A Sneak Peek At Providence Therapeutics On Cell & Gene: The Podcast 11/29/2023

    On an upcoming episode of Cell & Gene: The Podcast, I talk to Robert Georgantas III, Ph.D., of Providence Therapeutics, about their mRNA vaccine therapies. Here's a preview of our conversation.